Staidson(Beijing) Biopharmaceuticals Co.,Ltd. Posted 153.4 Million Yuan Net Loss in First Half of 2023

Staidson(Beijing) Biopharmaceuticals Co.,Ltd. (舒泰神(北京)生物制药股份有限公司) (300204.SZ) reported a net loss of 153.4 million yuan in the first half of 2023, widening 85.4% year-on-year.

Meanwhile, the company posted 169.4 million yuan in revenue, down 31.5% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 304 million yuan in total liabilities, with a liability-to-asset ratio of 19.9%.